Health Canada
www.hc-sc.gc.ca
Home
> Drugs & Health Products
> Drug Products
> Applications & Submissions
> Guidance Documents
> Common Technical Document (CTD)
Institutional links
-
Back to
-
Explore...
-
Transparency
Description of the Figure F-2: MF Type II - Container Closure Systems and Components
Figure F-2 - displays the sample module 1 to 3 folder structure requirements for a Master File Type II regulatory activity.
The Dossier Identifier should be “f” followed by seven numbers.
- Followed by, subfolder:
- Sub-subfolders:
- 1.0 Correspondence
- 1.0.1 Cover Letter
- 1.0.3 Copy of Health Canada Issued Correspondence
- 1.0.4 Health Canada Solicited Information
- 1.0.7 General Note to Reviewer
- 1.1 Table of Contents
- 1.2 Administrative Information
- 1.2.1 Application Form
- 1.2.2 Fee Forms
- 1.2.3 Certification and Attestation Forms
- 1.2.5 Compliance and Site Information
- 1.2.6 Authorization for Sharing Information
- 1.2.7 International Information
- 1.3 Product Information
- 1.3.6 Certified Product Information Document
- Subfolder for option:
- Sub-subfolders for option:
- 3.1 Table of Contents of Module 3
- 3.2 Body of Data
- 3.2.P Drug Product
- 3.2.P.7 Container Closure System
- Component X
- Component Y
- Component Z
- Subfolder for option:
- Sub-subfolders for option:
- 3.1 Table of Contents of Module 3
- 3.2 Body of Data
- 3.2.P Drug Product
- 3.2.P.1 Description and Composition of the Drug Product
- 3.2.P.3 Manufacture
- 3.2.P.3.1 Manufacturer(s)
- 3.2.P.3.3 Description of Manufacturing Process and Process Controls
- 3.2.P.3.5 Process Validation and/or Evaluation
- 3.2.P.5 Control of Drug Product
- 3.2.P.5.1 Specification(s)
- 3.2.P.5.2 Analytical Procedures
- 3.2.P.7 Container Closure System
- Component X
- Component Y
- Component Z
Two options are recommended for providing multiple components in the M3 folder.